Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
1 other identifier
interventional
183
1 country
1
Brief Summary
The effects of multiple sclerosis (MS) on cognition, thought to occur in 50-75% of persons with MS, have gained increasing recognition as one of the major disabling symptoms of the disease. While numerous studies have addressed the emotional and physical impact of MS, little attention has been given to strategies that might help manage the cognitive changes commonly experienced by persons with MS. The proposed study will test a novel computer-assisted cognitive rehabilitation intervention, MAPSS-MS (Memory, Attention, \& Problem Solving Skills for Persons with MS). The MAPSS-MS integrates the powerful effects of group interventions to build self-efficacy for new cognitive compensatory strategies/behaviors with individual home-based computer-assisted training. The computer training will assist individuals to develop cognitive skills that they can apply to everyday life using the compensatory strategies learned in the class sessions. In the recently completed exploratory study with 61 persons with MS (R21NR011076), the eight-week MAPSS-MS intervention was acceptable and feasible and had medium to large effects on the use of compensatory strategies and performance on neuropsychological tests of verbal memory. The proposed study will test the refined MAPSS-MS intervention with a larger more diverse sample (N=180) across multiple sites, extend the period of post-intervention follow-up to 6 months and establish whether performance improvements on neuropsychological tests make the important transfer to improved neuro-cognitive functioning in everyday life. The specific aims of this study are to: (1) Evaluate the efficacy of the novel MAPSS-MS cognitive rehabilitation intervention to improve overall neuro-cognitive competence in activities of daily living including verbal memory performance, use of compensatory cognitive strategies and performance on cognitive-related instrumental activities of daily living (IADL) among persons with MS; (2) Evaluate the efficacy of the MAPSS-MS intervention to improve self-efficacy and related aspects of cognitive performance (non-verbal learning/memory, information processing speed and attention, verbal fluency and complex scanning and tracking) among persons with MS; and (3) Determine the number of intervention participants who achieve and maintain their self-identified cognitive goals three and six months following the intervention. The effects of the intervention on outcome variables will be assessed using a randomized controlled trial design with a comparison group receiving usual care computer games. Measurements of study variables will occur at baseline, immediately after the MAPSS-MS intervention, and three months and six months after the intervention is complete. Statistical analysis will include descriptive statistics and HLM analysis to account for the nested design. The intent-to-treat approach will be used. Public Health Statement: This research will provide new knowledge about an innovative intervention to improve memory, use of compensatory strategies, and performance of cognitive activities and instrumental activities of daily living for persons with MS. If effective, the intervention would provide a new and feasible approach to target a serious, debilitating problem commonly experienced by persons with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started Jan 2014
Longer than P75 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 21, 2017
CompletedFirst Posted
Study publicly available on registry
June 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedResults Posted
Study results publicly available
July 10, 2024
CompletedJuly 10, 2024
July 1, 2024
4.2 years
June 21, 2017
November 29, 2018
July 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Neuro-cognitive Competence in Daily Living - California Verbal Learning Test-II
Verbal memory performance (verbal learning and remembering) as measured by performance on the California Verbal Learning Test II (CVLT-II). Total score represents the number of words recalled from a 16 item list over 5 trials. Higher scores represent greater verbal learning and remembering. Scores can range from 0 to 80.
6 months post-intervention
Use of Compensatory Cognitive Strategies
Scores on the Strategy Subscale of the Multi-Factorial Memory Memory Questionnaire. The subscale includes 19 various memory aids and strategies and respondents are asked to rate how frequently they used each strategy during the past 2 weeks using a 5 point scale (never to all the time). Scores can range from 0 to 76. HIgher scores indicate greater use of compensatory memory strategies.
6 months post-intervention
Cognitive-related Instrumental Activities of Daily Living (IADL) Among Persons With MS
Scores on the Everyday Problems Test - Revised (EPT-R). This scale assess the cognitive ability to reason and solve problems encountered in daily living. The revised version included 30 items and scores can range from 0 to 30. HIgher scores indicate better performance on problem solving.
6 months post intervention
Secondary Outcomes (5)
Self-Efficacy
6 months post intervention
Verbal Fluency
6 months post intervention
Nonverbal Learning and Memory
6 months post intervention
Auditory Information Processing Speed and Flexibility
6 months post intervention
Psychomotor Processing Speed
6 months post intervention
Study Arms (2)
Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)
EXPERIMENTALParticipants randomized to this arm receive the MAPSS-MS intervention. The MAPSS-MS is an an 8 week computer assisted cognitive rehabilitation intervention. The group based component of the intervention emphasizes use of compensatory cognitive strategies as well as lifestyle modifications to enhance cognition. Participants also complete home computer training (minimum 3 times per week for 45 minutes) using a special suite of games designed by Lumosity.
Usual Care plus Computer games
ACTIVE COMPARATORParticipants randomized to this arm receive usual care and are referred to MY BRAIN GAMES web site.
Interventions
MAPSS-MS is a computer-assisted cognitive rehabilitation intervention. It is a combination of home computer training and 8-weeks of group sessions on lifestyle change and compensatory cognitive strategies.
Participants assigned to this arm receive their usual medical care and referral to the "My Brain Games" website.
Eligibility Criteria
You may qualify if:
- Clinically definite diagnosis of MS;
- Age 18 to 60;
- Capable of understanding and complying with the study protocol;
- Able to read and write in English;
- Visual acuity of at least 20/70 with correction in order to work on the computer screen;
- Stable disease at the time of entry into the study (relapse free for at least 90 days);
- Subjective concerns about their cognitive functioning (based on the Perceived Deficits Questionnaire); and
- Home internet access;
You may not qualify if:
- Other medical causes of dementia or other neurological disorders that may impact cognition or emotions;
- Evidence of major psychiatric disorder; or
- Major functional limitations that preclude them from participating in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas at Austin
Austin, Texas, 78701, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Alexa Stuifbergen
- Organization
- The University of Texas at Austin
Study Officials
- PRINCIPAL INVESTIGATOR
Alexa Stuifbergen, PhD
University of Texas at Austin
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Care providers are not informed of the participant's participation in a particular arm. Staff collecting outcome data are not aware of the participant's assignment to intervention or usual care.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Dean
Study Record Dates
First Submitted
June 21, 2017
First Posted
June 27, 2017
Study Start
January 1, 2014
Primary Completion
March 1, 2018
Study Completion
June 1, 2018
Last Updated
July 10, 2024
Results First Posted
July 10, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- WIll be shared on request in 2020 and beyond
- Access Criteria
- Qualified investigators with IRB approval
Data files will be de-identified and data will be available on request to the investigators - estimated availability 2020